Previous studies demonstrated that B3GNT3 participates in the development and progression of human malignancies, such as pancreatic cancer, breast cancer, cervical cancer, lung cancer, and non-Hodgkin lymphoma [12–16]. This evidence concerns the gene B3GNT3 and breast cancer.